Germany's cannabis market is not on solid ground. It is being observed, evaluated, and politically discussed further. This is precisely why prescription marketing, artificial brand images, "bro-science," and reach-driven marketing are not mere footnotes. In the end, they can do more damage than many apparently realize.
Actually, the industry should be doing everything possible to build trust right now.
Instead, we see the opposite in many places.
There's playing with community where restraint would be appropriate. There's simulating authority with reach. There's hyping brands as if cannabis were just the next lifestyle playground. And some players are acting as if the difficult phase is already behind us, as if the political issue is settled, as if everyone can now forge ahead, impose their own logic on the market, and pretend that this will have no consequences.
That is precisely the misconception.
Because this legalization is not a relaxed conclusion. It is a sensitive transitional phase. A partial legalization. A system that is still being observed. A market that is far from firmly established. And precisely in such a phase, it's not just laws that determine the future of an issue, but also the people who shape its external image.
So the question right now is not just what is allowed.
The more important question is: What are we doing while we believe we have already won?
Far too little is being said about this.
Because, of course, everyone is talking about opportunities. About growth. About new markets. About reach, products, influential figures, communities, and brand building. But what is far too rarely stated is: The new cannabis market has a credibility problem. Not everywhere. Not with everyone. But clearly enough that it can no longer be dismissed as an isolated case.
And this problem doesn't just come from outside. It comes from the market itself.
"Partial legalization is not a free pass for every form of cannabis marketing. It's a leap of faith. And many are treating it as if they've received a blank check."
Tobi from CannaSelection
A young market cannot afford everything
Perhaps this is the clearest point to make: Cannabis in Germany is not simply here and done.
Yes, there's a new legal situation. Yes, there's movement. Yes, there are new possibilities. But to conclude from this that everything is already stable, secure, and fully accepted socially would be naive. The issue continues to be politically evaluated. Socially, it continues to be observed. And anyone who looks at the situation with any honesty also knows: there are enough forces just waiting to turn negative developments into new ammunition against the entire market.
This is precisely why many things weigh more heavily today than in a mature market.
In an established industry, a bad campaign is just a bad campaign. In a sensitive, young, and politically unsettled market, it can be more. It becomes a signal. Proof. An argument. An image that sticks.
And this is where responsibility begins.
Because whoever is now working with maximum attention, with artificial scarcity, with community facade, with hyped testimonials, with pseudo-authentic brand worlds, or with prescription-like emotionalization, is not just doing their own thing. They are shaping how this whole topic is perceived.
This is not a minor detail. This is central.
The problem isn't new players. The problem is the wrong incentives
One must remain fair on this point. New brands are not the problem. New voices are not either. New companies are not the problem either.
An open market always attracts new people. That's normal. And initially, that's a good thing.
The problem begins where quality, diligence, and responsibility are no longer rewarded, but primarily visibility. Where good marketing generates trust faster than genuine substance. Where loudness has more impact than nuance. Where someone appears credible, not because they are, but because they have learned what credibility looks like externally.
This is precisely the shift we are currently seeing in many places.
Attitude is feigned instead of genuinely held. Expertise is claimed because a camera is rolling. Proximity to the scene is staged because it converts well. Terms, images, and cultural codes are used that are supposed to convey depth, although often market logic is primarily behind them.
And the dangerous thing is: in a young market, that works.
Newcomers, in particular, often can't cleanly distinguish between genuine experience and well-packaged self-confidence. Between origin and staging. Between responsibility and performance. That's precisely why it's so fatal when visibility starts to feel like truth.
"New voices are not the problem. The problem begins when loudness is suddenly read as a substitute for substance."
Tobi from CannaSelection
Medical cannabis is not a playground for reach logic
It becomes particularly sensitive when the mechanisms of the attention market seep into areas where they simply do not belong.
Because medical cannabis is not just some loose lifestyle category. It's a sensitive pharmaceutical area. That's why strict limits apply there. And that's why it's so irritating to see how some companies operate externally in this environment.
Community hype. Emotionalized access logic. Lifestyle framing. Attention-grabbing imagery. Sometimes, it all looks as if a prescription-only area is being treated like a digital consumer product that just needs to be staged well enough to gain traction.
That's not modern. That's not progressive. It's not clever either.
It primarily shows that a part of the market has not understood the difference between reach and responsibility.
Especially in sensitive areas, the guiding question should be: How do you communicate in a way that builds trust without blurring boundaries? Instead, in some places, we see precisely the opposite impulse. As close as possible. As attractive as possible. As simple as possible. As adaptable as possible to the language and mechanisms that work well in other markets.
But that's precisely the fallacy here.
Not everything that attracts attention is legitimate in this market. And not everything that converts is therefore justifiable.
"Anyone who applies reach logic to sensitive pharmaceutical areas has not understood what this market should actually be about."
Tobi from CannaSelection
The new cannabis market is also shaped by bro-science
The second major blind spot is the question of who is currently providing guidance in the market.
With legalization, not only has a legal framework grown. A huge content space has also emerged. Suddenly, many more people are talking about growing, setup, products, microbiology, genetics, inputs, processes, error patterns, and system understanding. This could be a huge opportunity.
And in part, it is.
But it also has another side. Because in this new space of visibility, what is clear, loud, and simple is often rewarded. Not necessarily what is truly reliable. Not necessarily what is nuanced. Not necessarily what genuinely helps beginners.
The result is a market where "bro-science" can very quickly look like know-how.
Highly simplified statements are put out into the world. Half-truths are sold as principles. Proximity to sponsors and factual categorization are conflated. Setups are shown without mentioning the limits of one's own experience. And a form of self-assurance appears, which seems convincing primarily because it is simply well-packaged.
The problem with this is not just that some of it is technically flimsy. The problem is that it replaces genuine guidance.
Because those new to the topic seek stability. And if that stability first comes from people who have primarily learned how to sound confident, then a crooked market emerges. One in which genuine experience is often less visible than performed expertise.
Well-told brands are not automatically credible brands
This becomes even clearer with brand building.
Many brands emerging in the cannabis sphere today understand very well how to convey credibility. The visuals are spot on. The imagery is perfect. The codes feel familiar. The terms are well-chosen. The whole thing looks like the scene, sounds like the scene, and moves in a way that feels like genuine embeddedness to many.
But this is exactly where one must be careful.
Not every brand that looks like cannabis originated from cannabis. Not every origin story stands for genuine depth. Not every international narrative is proof of quality. And not every professionally packaged brand automatically brings the understanding it suggests externally.
Especially in the German market, we are currently seeing a high susceptibility to precisely such stagings. USA narratives, genetic promises, white-label worlds, grand aesthetics, grand words, grand effect. This works because the market is young. Because many yearn for orientation. Because storytelling in an early phase often generates trust faster than hard transparency.
There's nothing inherently wrong with that. Brand building is part of it. Of course.
The problem arises when staging begins to replace origin. Where marketing suddenly takes over the role of credibility. Where people think they are buying substance, but they are primarily buying a very neatly presented surface.
"Not every professionally presented cannabis brand is deeply anchored in content. The market needs to learn to distinguish between origin and staging."
Tobi from CannaSelection
Cannabis must not become merely a platform for attention now
Perhaps here lies the true core of the problem.
Cannabis is currently being treated by some players like an open advertising space. Like a topic to which one simply applies one's own logic. Reach, conversion, hype, community, sales, launch, new face, new code, new staging. All maximally visible, maximally emotional, maximally marketable.
But cannabis is not just a market. It is also a socially charged issue. One that in Germany did not arise from a relaxed consumer climate, but from years of prohibition, stigma, education, criminalization, counterculture, knowledge work, and political debate.
Anyone who ignores this may be loud in the short term. In the long term, however, they will not do justice to the topic.
Because a market like this needs more than capital and good framing. It needs integrity. It needs self-restraint. It needs people who understand that not every possible marketing mechanism is smart. And that growth without maturity can quickly backfire in such a phase.
All of this is not just bad optics. It is a real risk
Of course, one could downplay all of this. One could say: That's just how marketing is. That's how young markets function. That's just how it goes when a topic suddenly becomes big.
But that would be too convenient.
Because what we are seeing here is not just a matter of taste. It is not just a matter of style. It is not just a conflict between old and new players. It is a real risk for the perception of the entire field.
If the cannabis market primarily draws public attention where boundaries are maximally stretched, where community is instrumentalized, where reach replaces expertise, and where sensitive areas are played with the tools of digital attention, then precisely this image will stick.
And eventually, it will come back to haunt everyone.
To companies that operate cleanly.
To people who genuinely educate.
To patients who rely on seriousness.
To new consumers seeking guidance.
And to a legalization movement that is not yet on an unshakable foundation anyway.
"Anyone who prioritizes reach over responsibility today is not building a cannabis culture. They are damaging its political acceptance."
Tobi from CannaSelection
What we stand for
We are not against new market entrants.
We are not against professional brands.
We are not against growth.
And we are not against good communication.
But we are against market mechanisms that simulate trust instead of earning it. We are against artificially inflated credibility. Against "bro-science" that is sold as expertise. Against the blending of sensitive areas with hype and community mechanisms. And against any attitude that treats this partial legalization as if it were already unassailable.
CannaSelection stands for something different.
For nuance instead of posturing.
For substance instead of mere surface.
For responsibility instead of quick effect.
And for a cannabis market that earns credibility rather than buying it.
"Cannabis needs adults in the room right now. Not the next campaign that mistakes clicks for credibility."
Tobi from CannaSelection
The crucial question is not what is all possible now
The crucial question is what we make of this phase.
Do we turn this partial legalization into the beginning of a mature, credible, and responsible market? Or do we turn it into a showcase for precisely the mechanisms that will ultimately weaken the issue?
That's the crossroads we're at right now.
Legalization is not the problem.
But the market that some are now making of it is.
